Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Cystic Fibrosis Lung Disease
NCT00659529Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Aug 2008
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in cystic fibrosis (CF), sponsored by National Jewish Health. Started Aug 2008; status: completed.
02
Drugs
ASP-001
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00659529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659529.